Keyword Analysis & Research: portal vein thrombosis anticoagulation

bsg.org.uk

https://www.bsg.org.uk/web-education-articles-list/anticoagulation-for-portal-vein-thrombosis-a-quick-revision-aid/

There is considerable heterogeneity in the clinical presentation and course of portal vein thrombosis (PVT). It is useful to differentiate between acute and chronic PVT (either cirrhotic or non-cirrhotic) based on clinical presentation (Table 1).1–3

DA: 39 PA: 24 MOZ Rank: 2

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388284/

Jun 20, 2012 · Non-neoplastic portal vein thrombosis (PVT) is an increasingly recognized complication of liver cirrhosis. It is often diagnosed fortuitously and can be either partial or … Author: Geneviève Huard, Marc Bilodeau Publish Year: 2012

Author: Geneviève Huard, Marc Bilodeau

Publish Year: 2012

DA: 21 PA: 8 MOZ Rank: 79

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609842/

Jun 28, 2019 · Hypercoagulability leading to a prothrombotic state is the primary pathophysiological factor leading to PVT, underscored by the high incidence of concomitant … Author: Matthew Wu, Michael Schuster, Micheal Tadros CT: computed tomography Publish Year: 2019 DOAC: direct-acting oral anticoagulant

Author: Matthew Wu, Michael Schuster, Micheal Tadros

CT: computed tomography

Publish Year: 2019

DOAC: direct-acting oral anticoagulant

DA: 87 PA: 71 MOZ Rank: 71

nih.gov

https://pubmed.ncbi.nlm.nih.gov/29432256/

Summary: The goal of anticoagulation is to prevent thrombus extension to the superior mesenteric vein and/or favor recanalization if previously affected, allowing physiological … Author: Fanny Turon, Virginia Hernández-Gea, Juan Carlos García-Pagán Publish Year: 2018

Author: Fanny Turon, Virginia Hernández-Gea, Juan Carlos García-Pagán

Publish Year: 2018

DA: 93 PA: 72 MOZ Rank: 87

nih.gov

https://pubmed.ncbi.nlm.nih.gov/23314804/

Portal vein thrombosis (PVT) can contribute to significant morbidity and mortality; in patients with cirrhosis, this can make transplant more technically challenging. Additionally, the clot may … Author: Stephen E. Congly, Samuel S. Lee Publish Year: 2013

Author: Stephen E. Congly, Samuel S. Lee

Publish Year: 2013

DA: 21 PA: 73 MOZ Rank: 35

nih.gov

https://pubmed.ncbi.nlm.nih.gov/30578107/

Background and aims: Portal vein thrombosis (PVT) is a common complication of liver cirrhosis. Anticoagulation therapy is efficient, but is associated with potentially severe side-effects, …

DA: 99 PA: 46 MOZ Rank: 99

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415192/

Jan 06, 2015 · Portal vein thrombosis (PVT) refers to thrombosis that develops in the trunk of the portal vein including its right and left intrahepatic branches and may even extend to the …

DA: 21 PA: 96 MOZ Rank: 17

nih.gov

https://pubmed.ncbi.nlm.nih.gov/31293916/

The clinical management of portal vein thrombosis (PVT) remains ambiguous due to its heterogeneous presentations and its associations with liver disease, malignancy, and …

DA: 75 PA: 37 MOZ Rank: 86

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496897/

Nov 14, 2012 · We decided to perform anticoagulation therapy because the patient complained of abdominal pain, and serial CT scans showed the progression of the acute portal vein …

DA: 38 PA: 45 MOZ Rank: 65

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342267/

Aug 05, 2021 · Anticoagulation was continued for a period of one to two months after the complete recanalization of the portal vein depending on the original location and extent of the …

DA: 3 PA: 38 MOZ Rank: 11